	Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies. J Natl Cancer Inst Adams D, Hurson AN, Ahearn TU, Andrulis IL, Antoniou AC, Auvinen P, Bane A, Behrens S, Berrington de Gonzalez A, Bia, Bodelon C, Bolla MK, Borrero M, Brenner H, Brock IW, Broeks A, Camp NJ, Cessna MH, Chanock SJ, Chenevix-Trench G, Copson E, Couch FJ, Cox A, Cross SS, Devilee P, Dunning AM, Easton DF, Eccles DM, Figueroa JD, Glendon G, González-Neira A, Hamann U, Hartikainen JM, Hartman M, Heemskerk-Gerritsen BAM, Ho PJ, Hodge JM, Holleczek B, Hollestelle A, Hooning MJ, kConFab Investigators, SGBCC Investigators, Jakubowska A, Jones ME, Jones L, Jones B, Jung A, Kaaks R, Keeman R, Lawrence S, Li J, Lissowska J, Lubi, Mannermaa A, Manoochehri M, Martens JWM, Mesker WE, Muhammad N, Mulligan AM, Obi N, Olson JE, Osorio A, Ottewell PD, Patel AV, Pita G, Prajzendanc K, Rashid MU, Ruddy KJ, Safizadeh F, Schöttker B, Seibold P, Tapper WJ, Tengström M, Teras LR, Thorne H, Timmermans MAM, Tollenaar RAEM, Vachon CM, Wang Q, Wesseling J, Yadav S, Yang XR, Zamora MP, Chang-Claude J, Schmidt MK, Pharoah PDP, Abubakar M, García-Closas M. PMID: 42498670 [PubMed - as supplied by publisher]
	The Role of Immunotherapy in Breast Cancer and Mechanisms of Immune Escape: What Surgeons Need to Know. Am Surg Graham DM, Lofftus S, Azizi L, Berkowitz MJ, Teshome M. PMID: 42498515 [PubMed - as supplied by publisher]
	AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update. Breast Hartkopf A, Albert US, Bartsch R, Bauerfeind I, Banys-Paluchowski M, Bjelic-Radisic V, Blohmer JU, Dall P, Fallenberg EM, Fasching PA, Friedrich M, Gluz O, Harbeck N, Heil J, Hörner-Rieber J, Huober J, Janni W, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, van Mackelenbergh MT, Mundhenke C, Park-Simon TW, Reinisch M, Reimer T, Rhiem K, Rody A, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thill M, Untch M, Witzel I, Wöckel A, Wuerstlein R, Ditsch N, Fehm T, Müller V, Schmidt M. PMID: 42497646 [PubMed - as supplied by publisher]
	Pre-operative Nutritional Risk Screening 2002-based nomograms for predicting post-operative complications after cytoreductive surgery for ovarian cancer: a multi-center retrospective cohort study. Int J Gynecol Cancer Chu R, Hu W, Zhang D, Song X, Tian W, Zhao Y, Wang H, Liu M. PMID: 42497581 [PubMed - as supplied by publisher]
	Patients With Luminal Breast Carcinoma: The State of the Field in Proteomic and Proteogenomic Molecular Subtyping. Clin Breast Cancer Alexovi, Sabo J, Bouchal P. PMID: 42497535 [PubMed - as supplied by publisher]
	Evaluating the diagnostic performance of exosome biomarkers for the detection of ovarian cancer: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol Li DM, Pei KG, Yu XZ, Li MZ, Yuan MW, Qie MR, Hou MM. PMID: 42497533 [PubMed - as supplied by publisher]
	Nurse-led attribution remodeling training based on the Neuman systems model to enhance resilience, adaptive coping, and attributional style in women newly diagnosed with breast cancer: A randomized controlled trial. Int J Nurs Stud Zhou K, Yang L, Yao C, Guo A, Zhao F, Zhang H. PMID: 42497495 [PubMed - as supplied by publisher]
	Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study. ESMO Open Rugo HS, Jhaveri K, Pernas S, Pistilli B, Im SA, De Laurentiis M, Wang S, Martínez Jañez N, Borges G, Cescon DW, Hattori M, Lu YS, Hamilton E, Zhang Q, Tsurutani J, Kalinsky K, Rubini Liedke PE, Nowecki Z, Tolaney SM, Zhao K, Atuah K, Verma D, Xu B, Bardia A, TROPION-Breast01 investigators. PMID: 42497483 [PubMed - as supplied by publisher]
	A rare case of bilateral axillary accessory breast tissue coexisting with prolactinoma in an adolescent girl. Turk J Pediatr Kontbay Çetin T, Samut Bülbül S. PMID: 42497440 [PubMed - indexed for MEDLINE]
	Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis. PLoS One Arafat HM, Ali A, Tengku Din TADAA, Shamallakh OM, Jusoh R, Yahya MM, Zain WZW, Rahman WFWA. PMID: 42497233 [PubMed - indexed for MEDLINE]
	The health management pathway of breast cancer patients: an exploratory study using patient journey mapping. Psychol Health Med Shen M, Shen Y, Gao Y, Jiang N, Cai L. PMID: 42497118 [PubMed - as supplied by publisher]
	BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis. Breast Cancer Reveneau MF, De Pauw A, Masliah-Planchon J, Decees A, Lakhlifi S, Pasanisi J, Gall JL, Schwartz M, Pagès M, Pierre-Noël E, Sebai M, Caputo SM, Moncoutier V, Tenreiro H, Berthemin C, Carrière J, Dubois d'Enghien C, Abidallah K, Guy C, Fort N, Zaguia N, Taribo AC, Grati OT, Lori L, Maillard A, Benoist C, Frouin E, Merchadou K, Quinquis F, Filser M, Delhomelle H, Le Mentec M, Warcoin M, Bertrand O, Villy MC, Saule C, Mouret-Fourme E, Gauthier-Villars M, Buecher B, Popova T, Stern MH, Renault V, Pasmant E, Stoppa-Lyonnet D, Colas C, Golmard L. PMID: 42496958 [PubMed - as supplied by publisher]
	Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy. J Neurooncol Zhu JW, Fernandes I, Lopes JB, Moravan V, Tran W, Jerzak KJ. PMID: 42496928 [PubMed - indexed for MEDLINE]
	Associations of neighborhood racial and ethnic, economical, and educational segregation with breast cancer risk: The Multiethnic ohort Study. Cancer Causes Control Ihenacho U, Khan-Gates J, Lin K, Abe JV, Inamdar PP, Yang J, Li Y, Sangaramoorthy M, Haiman CA, Le Marchand L, Wilkens LR, Gomez SL, Shariff-Marco S, Wu AH, Cheng I. PMID: 42496782 [PubMed - indexed for MEDLINE]
	SERENA-6 visual patient-reported outcomes & safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy. Oncologist Brufsky A, Park YH, Bidard FC, Mayer EL, Janni W, Ma C, Cristofanilli M, Bianchini G, Iwata H, Fasching PA, Nowecki Z, Pascual J, Chen SC, Moreau L, Ruiz-Borrego M, Shai A, Karadurmus N, Jung KH, Kikawa Y, Baird RD, Habash R, Sugarman R, Fox S, Selvi Miralles M, Bartlett CH, Turner N. PMID: 42496653 [PubMed - as supplied by publisher]
	Epigenetic Mechanisms of Breast and Ovarian Cancer Development: Interplay Between DNA Methylation/Demethylation Enzymes, MicroRNAs, and Long Non-Coding RNAs. Epigenomes Lukina SS, Pronina IV, Bril AA, Burdennyy AM, Loginov VI, Morozov SG. PMID: 42496533 [PubMed]
	Exercise-Induced Circulating Lactate Responses in Breast Cancer Survivors: A Systematic Review and Exploratory Meta-Analysis. Muscles Ahmadi Hekmatikar AH, Santamaría G, Celorrio San Miguel AM, Roche E, Khodadadi F, López-Llorente Á, Fernández-Lázaro D. PMID: 42496378 [PubMed]
	Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment. Radiol Imaging Cancer Le NN, Li W, Wilmes LJ, Onishi N, Gibbs JE, Hathi D, Metanat P, Joe BN, Kornak J, Malyarenko D, Chenevert TL, Bolan P, Partridge SC, Hylton NM. PMID: 42496228 [PubMed - indexed for MEDLINE]
	Inavolisib: a second-generation PI3KÎ± inhibitor in HR+/HER2-negative breast cancer. Expert Opin Drug Metab Toxicol Abdy E, Betancourt JP, Kar S. PMID: 42496151 [PubMed - as supplied by publisher]
	Efficient high-risk human papillomavirus screening through pooled testing: a simulation study based on real-world data in low- and middle-income countries. J Glob Health Pan F, Greuter MJ, Koot JA, Cubie H, Nazrul N, Nakisige C, Beltman J, de Bock GH, van der Schans J. PMID: 42495948 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 332682

Page 1 of 16635



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy